2013
DOI: 10.1177/0218492312446838
|View full text |Cite
|
Sign up to set email alerts
|

Does use of cell saver decrease the inflammatory response in cardiac surgery?

Abstract: Our results suggest that cell salvage in low-risk patients undergoing their first elective cardiac procedure does not decrease the inflammatory response after surgery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 19 publications
0
7
0
Order By: Relevance
“…Intraoperation autologous blood transfusion is an effective method that is used in surgeries with an important blood loss. One study has proved the use of a cell saver may reduce proinflammatory cytokine concentrations in patients undergoing cardiac surgery [19].…”
Section: Discussionmentioning
confidence: 99%
“…Intraoperation autologous blood transfusion is an effective method that is used in surgeries with an important blood loss. One study has proved the use of a cell saver may reduce proinflammatory cytokine concentrations in patients undergoing cardiac surgery [19].…”
Section: Discussionmentioning
confidence: 99%
“…Blood transfusions alter humoral and cellular immunity in the recipient, particularly in the setting of cardiac surgery with cardiopulmonary bypass (CPB) (16); a procedure which in children, routinely requires red blood cell (RBC) transfusion (7,8). Children receiving greater numbers of RBC transfusions have increased post-operative complications and mortality (914).…”
Section: Introductionmentioning
confidence: 99%
“…Prieto et al did not find a decrease of inflammatory response after CS investigating interleukin 1β, 6, 8, and 12, p40 subunit of interleukin 23 and interferon γ. 6 Bauer et al described an attenuating effect of CS during MECC on the course of TNFα but not for C-reactive protein and procalcitonin. 7 In our recent comparison out of several investigated inflammation markers TNFα, sICAM, and Pselectin showed some differences in time courses comparing ONCAB with MECC or OPAB.…”
Section: Discussionmentioning
confidence: 98%